Newsroom | 199903 results
Sorted by: Latest
-
Swisslog Healthcare Elevates Jennie McQuade to Global Chief Legal Counsel & Privacy Officer
BROOMFIELD, Colo.--(BUSINESS WIRE)--Swisslog Healthcare, a global leader in pharmacy and transport automation solutions, announces the promotion of Jennie McQuade to Global Chief Legal Counsel & Privacy Officer. This appointment recognizes McQuade's decade-long commitment to enhancing data security and privacy in the healthcare industry. "Jennie’s leadership has been instrumental in strengthening our security posture and navigating complex global privacy regulations.” said Cory Kwarta, CEO...
-
CareDx Announces Appointment of Nathan Smith as Chief Financial Officer
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA), — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced the appointment of Nathan Smith to the role of Chief Financial Officer. Nathan will lead key financial and accounting initiatives that are a part of the Company’s long-term strategic growth p...
-
Denise McQuaide Named Chief of Middle Market Innovation at 2Life Communities
BRIGHTON, Mass.--(BUSINESS WIRE)--Denise McQuaide has stepped into the role of Chief of Middle Market Innovation at 2Life Communities, a leading affordable senior housing developer, owner, operator, and advocate in the Greater Boston area. A 40-year veteran of healthcare, senior living operations, and community health services industries, McQuaide has served 2Life as a strategic advisor for four years, guiding its healthcare and housing integration approach. In this newly formed role, she will...
-
U.S. Physical Therapy Reports Second Quarter 2025 Results
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today reported results for the three and six months ended June 30, 2025. FINANCIAL HIGHLIGHTS Adjusted EBITDA (1), a non-Generally Accepted Accounting Principles (“GAAP”) measure, was $26.9 million for the three months ended June 30, 2025 (“2025 Second Quarter”), an increase of $4.7 million...
-
Innovative Industrial Properties Announces Strategic and Diversifying $270 Million Investment in Life Science Real Estate Platform
SAN DIEGO--(BUSINESS WIRE)--Innovative Industrial Properties, Inc. (NYSE: IIPR) (“IIP” or the “Company”), announced today that it entered into agreements to make an investment totaling up to $270 million into IQHQ, Inc. (“IQHQ”), a premier life science real estate platform with over $5 billion in total assets. The investment (the “Investment,” “Transaction,” or “Investment Transaction”) is comprised of two discrete investments that together are expected to earn a weighted average interest rate...
-
Cresco Labs Announces Commitments to Refinance its Senior Secured Credit Facility
CHICAGO--(BUSINESS WIRE)--Cresco Labs Announces Commitments to Refinance its Senior Secured Credit Facility...
-
AngioDynamics to Present at the Canaccord Genuity 45th Annual Growth Conference
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the Canaccord Genuity 45th Annual Growth Conference at 9:0...
-
Stoke Therapeutics to Present at the Canaccord Genuity 45th Annual Growth Conference
BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today announced that Interim Chief Executive Officer Ian F. Smith will present at the Canaccord Genuity 45th Annual Growth Conference on Wednes...
-
Bitcoin-Native, Institutional Digital Asset Management Platform Parataxis Holdings to Go Public via Combination with SilverBox Corp IV
AUSTIN, Texas & NEW YORK--(BUSINESS WIRE)--Parataxis Holdings LLC (“Parataxis Holdings” or the “Company”), a preeminent, institutional digital asset management platform founded by principals of Parataxis Capital Management LLC (“PCM”), today announced it has entered into a definitive business combination agreement with SilverBox Corp IV (“SBXD”) (NYSE: SBXD), a publicly listed special purpose acquisition company sponsored by SilverBox Sponsor IV (the “Sponsor”), an affiliate of SilverBox Capita...
-
Enhabit Home Health & Hospice Announces CEO Transition Plan
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, today announced that Barb Jacobsmeyer, president and CEO, and a member of the board of directors, intends to step down from these roles in July 2026, or upon the appointment of a successor. The company has initiated a leadership succession plan with Jacobsmeyer’s full support to ensure a smooth transition. The board has retained Russell Reynolds Associates, a leading executive search firm, to assist...